Q1 results on May 09, 2012

| Updated on November 15, 2017 Published on April 11, 2012

Ranbaxy Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 09, 2012, inter-alia, to consider Standalone and Consolidated Unaudited Financial Results for the quarter ended March 31, 2012 as reviewed by the Statutory Auditors of the Company.

Source : BSE - >

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on April 11, 2012
This article is closed for comments.
Please Email the Editor